Impotence Treatments

Latest Health Related News:
1 in 12 Outpatient Visits Is for Prevention: Study (HealthDay)
In the United States, preventive health exams account for about 1 in 12 adult outpatient visits to doctors, says a study that found that, each year between 2002 and 2004, about 63.5 million adults had a preventive health or gynecological check-up, at an annual cost of $7.8 billion.
Rabies Vaccine Development At UGA Receives NIH Grant
The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has awarded the University of Georgia College of Veterinary Medicine a $1.18 million grant to develop rabies virus vaccines. This award is the continuation of a previous four-year $837,000 grant issued by NIAID in 2002 to initiate the study.
Aclasta(R) Receives European Approval As First Once-yearly Treatment For Postmenopausal Osteoporosis
Aclasta® (zoledronic acid 5 mg) has gained European Union approval as the first and only once-yearly treatment for women with postmenopausal osteoporosis. The announcement closely follows the recent approval in the US, where the Food and Drug Administration (FDA) approved Aclasta under the brand name Reclast® in August 2007. The European Commission decision applies to all 27 member states, Norway and Iceland.